On Monday, March 31, a court in the Eastern District of Texas found unlawful and vacated the Food and Drug Administration’s ...

On March 31, a judge in the Eastern District of Texas vacated the US Food and Drug Administration’s (FDA) rule that sought to ...

Given the continued challenges in policing the burgeoning ENDS marketplace, as previously discussed in Part I of this article, in mid-2024 FDA and ...

Yesterday the U.S. District Court for the Northern District of California granted summary judgment to FDA and drug ...

A lower court will reconsider whether the agency should have considered an e-cigarette manufacturer's marketing plan.

The summary presents key developments affecting the health sector, including disruptions in the FDA due to Trump's layoffs, ...

The health sector faces significant challenges due to recent actions from the Trump administration. Key issues include tariffs on Indian pharmaceuticals, FDA staffing changes, legal battles over drug ...

The Supreme Court on Wednesday backed a series of decisions by the US Food and Drug Administration to deny market access for flavored vaping products in a rare win for government regulators that ...

Supply issues finally started to ease late in 2024, as compounded semaglutide — "copycats" of the patented stuff like Ozempic and Zepbound — began to flood the market when the FDA temporarily ...